The global metabolomics market size reached US$ 2.4 Billion in 2022. Looking forward, the publisher expects the market to reach US$ 4.7 Billion by 2028, exhibiting a growth rate (CAGR) of 11.85% during 2022-2028.
Metabolomics refers to the large-scale study of metabolites, or small molecules, in cells, biofluids, tissues and organisms. It is an analytical approach for systematic metabolic profiling and fingerprinting in various biological samples and systems. It consists of various detection techniques, such as nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry (MS), along with separation techniques, such as gas chromatography. These techniques are commonly used for metabolome studies, toxicology testing and developing personalized medicine. They also provide an assessment of health and an insight into the causes and treatment of medical ailments, such as cardiovascular and neurological diseases and cancer.
The increasing prevalence of cancer and other chronic diseases is one of the key factors driving the growth of the market. Furthermore, a significant increase in the pharmaceutical industry, along with the rising demand for personalized medicines, is also providing a boost to the market growth. Metabolomics facilitates the study of genes and proteins, along with the development of biomarkers that aid in the discovery and development of medicines and managing disease progression. Additionally, the integration of metabolomics with machine learning (ML) is also favoring the market growth. ML aids in the accurate interpretation of data generated using the NMR and MS techniques and automates complex, repetitive and time-consuming processes. Advanced ML software also offers comprehensive analysis and visualization functions for the representation of large amounts of data. Other factors, including rapid urbanization and extensive research and development (R&D) activities in the field of biotechnology, are projected to drive the market in the upcoming years.
Metabolomics refers to the large-scale study of metabolites, or small molecules, in cells, biofluids, tissues and organisms. It is an analytical approach for systematic metabolic profiling and fingerprinting in various biological samples and systems. It consists of various detection techniques, such as nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry (MS), along with separation techniques, such as gas chromatography. These techniques are commonly used for metabolome studies, toxicology testing and developing personalized medicine. They also provide an assessment of health and an insight into the causes and treatment of medical ailments, such as cardiovascular and neurological diseases and cancer.
The increasing prevalence of cancer and other chronic diseases is one of the key factors driving the growth of the market. Furthermore, a significant increase in the pharmaceutical industry, along with the rising demand for personalized medicines, is also providing a boost to the market growth. Metabolomics facilitates the study of genes and proteins, along with the development of biomarkers that aid in the discovery and development of medicines and managing disease progression. Additionally, the integration of metabolomics with machine learning (ML) is also favoring the market growth. ML aids in the accurate interpretation of data generated using the NMR and MS techniques and automates complex, repetitive and time-consuming processes. Advanced ML software also offers comprehensive analysis and visualization functions for the representation of large amounts of data. Other factors, including rapid urbanization and extensive research and development (R&D) activities in the field of biotechnology, are projected to drive the market in the upcoming years.
Key Market Segmentation:
The publisher provides an analysis of the key trends in each sub-segment of the global metabolomics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, indication and application.Breakup by Product:
- Metabolomics Instruments
- Metabolomics Bioinformatics Tools and Services
Breakup by Indication:
- Cancer
- Cardiovascular Disorders
- Neurological Disorders
- Inborn Errors of Metabolism
- Others
Breakup by Application:
- Biomarker and Drug Discovery
- Toxicology
- Nutrigenomics
- Personalized Medicine
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined with some of the key players being Agilent Technologies Inc., Biocrates Life Sciences AG, Bio-Rad Laboratories Inc., Bruker Corporation, Danaher Corporation, Human Metabolome Technologies Inc., Metabolon Inc., Shimadzu Corporation, Thermo Fisher Scientific Inc., Waters Corporation, etc.Key Questions Answered in This Report:
- How has the global metabolomics market performed so far and how will it perform in the coming years?
- What are the key regional markets?
- What has been the impact of COVID-19 on the global metabolomics market?
- What is the breakup of the market based on the product?
- What is the breakup of the market based on the indication?
- What is the breakup of the market based on the application?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global metabolomics market and who are the key players?
- What is the degree of competition in the industry?
Table of Contents
1 Preface2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Metabolomics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Metabolomics Instruments
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Metabolomics Bioinformatics Tools and Services
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Indication
7.1 Cancer
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Cardiovascular Disorders
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Neurological Disorders
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Inborn Errors of Metabolism
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by Application
8.1 Biomarker and Drug Discovery
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Toxicology
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Nutrigenomics
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Personalized Medicine
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Competitive Landscape
13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
13.3.1 Agilent Technologies Inc.
13.3.1.1 Company Overview
13.3.1.2 Product Portfolio
13.3.1.3 Financials
13.3.1.4 SWOT Analysis
13.3.2 Biocrates Life Sciences AG
13.3.2.1 Company Overview
13.3.2.2 Product Portfolio
13.3.3 Bio-Rad Laboratories Inc.
13.3.3.1 Company Overview
13.3.3.2 Product Portfolio
13.3.3.3 Financials
13.3.3.4 SWOT Analysis
13.3.4 Bruker Corporation
13.3.4.1 Company Overview
13.3.4.2 Product Portfolio
13.3.4.3 Financials
13.3.5 Danaher Corporation
13.3.5.1 Company Overview
13.3.5.2 Product Portfolio
13.3.5.3 Financials
13.3.5.4 SWOT Analysis
13.3.6 Human Metabolome Technologies Inc.
13.3.6.1 Company Overview
13.3.6.2 Product Portfolio
13.3.6.3 Financials
13.3.7 Metabolon Inc.
13.3.7.1 Company Overview
13.3.7.2 Product Portfolio
13.3.8 Shimadzu Corporation
13.3.8.1 Company Overview
13.3.8.2 Product Portfolio
13.3.8.3 Financials
13.3.8.4 SWOT Analysis
13.3.9 Thermo Fisher Scientific Inc.
13.3.9.1 Company Overview
13.3.9.2 Product Portfolio
13.3.9.3 Financials
13.3.9.4 SWOT Analysis
13.3.10 Waters Corporation
13.3.10.1 Company Overview
13.3.10.2 Product Portfolio
13.3.10.3 Financials
13.3.10.4 SWOT Analysis
List of Figures
Figure 1: Global: Metabolomics Market: Major Drivers and Challenges
Figure 2: Global: Metabolomics Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Metabolomics Market: Breakup by Product (in %), 2022
Figure 4: Global: Metabolomics Market: Breakup by Indication (in %), 2022
Figure 5: Global: Metabolomics Market: Breakup by Application (in %), 2022
Figure 6: Global: Metabolomics Market: Breakup by Region (in %), 2022
Figure 7: Global: Metabolomics Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 8: Global: Metabolomics (Instruments) Market: Sales Value (in Million US$), 2017 & 2022
Figure 9: Global: Metabolomics (Instruments) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 10: Global: Metabolomics (Bioinformatics Tools and Services) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Metabolomics (Bioinformatics Tools and Services) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Metabolomics (Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Metabolomics (Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Metabolomics (Cardiovascular Disorders) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Metabolomics (Cardiovascular Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Metabolomics (Neurological Disorders) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Metabolomics (Neurological Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Metabolomics (Inborn Errors of Metabolism) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Metabolomics (Inborn Errors of Metabolism) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Metabolomics (Other Indications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Metabolomics (Other Indications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Metabolomics (Biomarker and Drug Discovery) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Metabolomics (Biomarker and Drug Discovery) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Metabolomics (Toxicology) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Metabolomics (Toxicology) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: Metabolomics (Nutrigenomics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: Metabolomics (Nutrigenomics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: Global: Metabolomics (Personalized Medicine) Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: Global: Metabolomics (Personalized Medicine) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: Global: Metabolomics (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: Global: Metabolomics (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: North America: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: North America: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: United States: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: United States: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: Canada: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: Canada: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: Asia Pacific: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: Asia Pacific: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: China: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: China: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: Japan: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: Japan: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: India: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: India: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: South Korea: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: South Korea: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: Australia: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: Australia: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Indonesia: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: Indonesia: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: Others: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: Others: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: Europe: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: Europe: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: Germany: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: Germany: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: France: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: France: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: United Kingdom: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: United Kingdom: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Italy: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Italy: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: Spain: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: Spain: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: Russia: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: Russia: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Others: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: Others: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Latin America: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: Latin America: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: Brazil: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Brazil: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 74: Mexico: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 75: Mexico: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 76: Others: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 77: Others: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 78: Middle East and Africa: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 79: Middle East and Africa: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 80: Global: Metabolomics Industry: SWOT Analysis
Figure 81: Global: Metabolomics Industry: Value Chain Analysis
Figure 82: Global: Metabolomics Industry: Porter’s Five Forces Analysis
List of Tables
Table 1: Global: Metabolomics Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Metabolomics Market Forecast: Breakup by Product (in Million US$), 2023-2028
Table 3: Global: Metabolomics Market Forecast: Breakup by Indication (in Million US$), 2023-2028
Table 4: Global: Metabolomics Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 5: Global: Metabolomics Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 6: Global: Metabolomics Market: Competitive Structure
Table 7: Global: Metabolomics Market: Key Players
Companies Mentioned
- Agilent Technologies Inc.
- Biocrates Life Sciences AG
- Bio-Rad Laboratories Inc.
- Bruker Corporation
- Danaher Corporation
- Human Metabolome Technologies Inc.
- Metabolon Inc.
- Shimadzu Corporation
- Thermo Fisher Scientific Inc.
- Waters Corporation
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 143 |
| Published | March 2023 |
| Forecast Period | 2022 - 2028 |
| Estimated Market Value ( USD | $ 2.4 Billion |
| Forecasted Market Value ( USD | $ 4.7 Billion |
| Compound Annual Growth Rate | 11.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
